Dr. Siffert began his career in industry at Pfizer, where he held medical roles of increasing responsibility from 2002 to 2005. He earned a medical degree (M.B.B.S.) On Buzzfile's Professional (subscription) Servicewe have 19 contacts for Abeona Therapeutics LLC What is the internet address for Abeona Therapeutics? More recently, his work is included clinical trials and studies of factors that impact the function of children with movement disorders. From 2010 to 2012, Ms. Maximenko worked in Employee Relations Operations at Macquarie, an Australian investment bank, where she supported three business groups in all phases of employee lifecycle, international assignments and compliance. Report incorrect company information . Prior to her current role, she served as Chief Financial Officer for Abeona. Dr. Augustine’s research interests include methodology of clinical research and experimental therapeutics in rare pediatric neurological disorders.
He also held roles of increasing responsibility at Organon, Elusys Therapeutics, and the Population Council. He was also Manager of Regulatory Affairs for MCM (Merck-Connaught-Merieux), developing novel combination pediatric vaccines.
He is also on the physician team for Nationwide Children’s world-class Neuromuscular Disorders program, which provides coordinated care with pediatric experts from more than a dozen specialties.Dr. Dr. Siffert also led the R&D, medical, regulatory, compliance, manufacturing and quality organizations at Avanir Pharmaceuticals from 2011 to 2016. Migausky brings more than 30 years of experience in senior financial management to Abeona’s Board, having served as Chief Financial Officer (CFO) of several public biopharmaceutical and clinical diagnostic companies. 100 % Tweets with engagement. Mr. Nogi earned his MBA in management and strategy from the Stern School of Business at New York University and his BFA also from New York University.Dr. Fact Sheet. Most recently, he served as CFO at PolarityTE, Inc., a biotechnology and regenerative biomaterials company, where he was responsible for all financial operations. He performed a postdoctoral fellowship focusing on gene therapy in the laboratory of Jude Samulski at UNC-Chapel Hill. Dr. Wider holds an M.D. Later in his tenure at BD, Mr. Bircher served as Head of Manufacturing where he was responsible for all formulation, fill and packaging operations. Most recently, he was the Chief Scientific and Medical Officer for Nestle Health Science, where he led translational research, clinical development and operations, regulatory, medical affairs, and health economics. Silverstein began her career in financial services as an investment advisor at Royal Alliance Associates before moving to the investor and corporate relations industry. In addition to his clinical practice and research, he directs the Child Neurology residency at the University of Rochester. Twitter Engagement Stats for @ AbeonaBio. 2.8. He has serves on the Scientific Advisory Board of Aptose Biosciences and has had extensive consulting experience. Most recently, Mr. Migausky served as interim CFO of Ocular Therapeutix, Inc. and previously served as Executive Vice President and CFO of Dyax Corp. for eight years through its acquisition by Shire plc for $6.4 billion. degree magna cum laude from the University of Massachusetts Dartmouth.Kristina Maximenko joined Abeona as Vice President of Human Resources in 2018, bringing significant experience in multiple functional areas such as recruitment, employee relations, organizational development and employment law with a focus on rapidly growing small- to medium-size companies. Dr. Escolar is board-certified in neurodevelopmental disabilities. from Columbia College of Physicians and a B.A. Autologous gene-corrected cell therapy for patients with RDEB.In Phase 1/2 development. She has 15 years of experience as a practicing clinician and researcher. Mr. Carr has significant experience managing various accounting, financial reporting, internal controls, tax and treasury matters.